| (SEK) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 13.42M | — |
| Operating expense | — | — |
| Net income | -119.22M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BINV.ST returned -35.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -17.3% |
| 1 year | -35.7% |
| 5 years | -49.6% |
| 10 years | -53.4% |
| All-time high | kr 920.63 (Jun 2001) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in BINV.ST would be worth today ›No. BioInvent International AB (publ) has not paid a dividend in the past 12 months.
BioInvent International AB (publ) is part of the Healthcare sector.
BioInvent International AB (publ) has a market cap of 1.60B SEK, based on the latest quote.
BioInvent International AB (publ) is scheduled to report earnings on Aug 27, 2026.
